Sign in
4

Changes in Ownership

OnKure Therapeutics, Inc. Filed Acc 0001209191-22-016541

Options or other derivatives

  • Chief Operating Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cruse Michael · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-02 Grant or award : show line 1 in the form Stock option (right to buy) +25,000 25,000 D
Loading xslF345X03/doc4.xml…